The Importance of Pharmacogenomics in the Context of Biobanking

Add bookmark

Pharma IQ

Dr. Lynn Dressler, Assistant Professor at the Eshelman School of Pharmacy and Associate Director for Policy and Ethics at the Institute for Pharmacogenomics and Individualised Therapy at the University of North Carolina, Chapel Hill, joins Amber Scorah from Pharma IQ, to discuss important ethical, social and policy issues that surround the use of specimens in pgX research, and the importance of pharmacogenomics in the context of biobanking. [inlinead]
To continue reading this story get free access